Metastatic Melanoma - Doublet vs Triplet therapy

preview_player
Показать описание
Ryan Sullivan @MassGeneralHospital and @OmidHamidMD from The Angeles Clinic and Research Institute discuss doublet vs. triplet therapy for melanoma. Newer breakthroughs coming. @ImmunoOncology
  1. ImmunoOncology
  2. melanoma
  3. oncology
  4. immunotherapy
  5. immunooncology
  6. Skin cancer
Рекомендации по теме
Metastatic Melanoma - 0:30:46

Metastatic Melanoma - Doublet vs Triplet therapy

2020 MELANOMA - 0:06:55

2020 MELANOMA - MCKEAN - Combination Immunotherapy vs Monotherapy for Metastatic Melanoma

Facilitating Progress in 0:51:59

Facilitating Progress in the Treatment of SCLC

SCLC: Therapeutic progress 0:17:10

SCLC: Therapeutic progress or mirage?

Triplet therapies for 0:06:58

Triplet therapies for advanced metastatic melanoma

Hitting the Mark 0:20:35

Hitting the Mark with Targeted Therapy: BRAF, NRAS, CKIT, etc...Sullivan

Debate: MSI High 0:07:37

Debate: MSI High Colon Cancer - Upfront Chemotherapy

I DID NOT 0:08:21

I DID NOT EXPECT THAT. Metastatic Melanoma.

Nivolumab + Ipilimumab 0:08:45

Nivolumab + Ipilimumab vs Platinum-doublet Chemotherapy as First-line Treatment for Advanced NSCLC

What can be 0:01:03

What can be achieved with triple combination therapy Phase I trial for metastatic melanoma

Dr. Sullivan on 0:02:07

Dr. Sullivan on Considerations for Treatment in Metastatic Melanoma

Metastatic Melanoma: Clinical 0:04:42

Metastatic Melanoma: Clinical Pearls From the Experts

Treatment Algorithms in 0:48:03

Treatment Algorithms in Melanoma: Evaluating Where We Are and Where We Are Headed

CheckMate 816 trial: 0:06:04

CheckMate 816 trial: Nivolumab + platinum-doublet chemotherapy vs chemo as neoadjuvant treatment...

The Development of 0:25:55

The Development of Therapies in Metastatic Melanoma- Dr. Patel Melanoma Education Symposium 2014

Novel Therapies for 0:20:39

Novel Therapies for Metastatic Melanoma - Melanoma Education Symposium, Omid Hamid MD

GI ASCO 2020 0:58:58

GI ASCO 2020 Recap Webinar

Novel triple combination 0:01:42

Novel triple combination therapies for melanoma

Checkpoint Inhibitors: Combination 0:07:51

Checkpoint Inhibitors: Combination Therapy in Melanoma

Treatment selection for 0:01:17

Treatment selection for stage III BRAF-mutant melanoma

Addition of relatlimab 0:04:21

Addition of relatlimab to nivolumab plus platinum-doublet chemotherapy demonstrates improved cli...

BRAF-Mutated mCRC: From 1:35:47

BRAF-Mutated mCRC: From Diagnosis to Treatment

Advances in Melanoma 0:57:19

Advances in Melanoma Cancer Treatment

Nivolumab + Ipilimumab 0:10:12

Nivolumab + Ipilimumab + 2 Cycles of Platinum-doublet Chemo vs 4 Cycles Chemo for Stage IV NSCLC